ORIGINAL RESEARCH article

Front. Public Health

Sec. Infectious Diseases: Epidemiology and Prevention

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1597076

Global burden of diphtheria, 1990-2021: A 204-country analysis of socioeconomic inequality based on SDI and DTP3 vaccination differences before and after the COVID-19 pandemic (GBD 2021)

Provisionally accepted
  • 1Guangzhou University of Chinese Medicine, Guangzhou, China
  • 2First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China
  • 3Guangdong Clinical Research, Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China

The final, formatted version of the article will be published soon.

Objective: This study aimed to comprehensively assess the temporal trends and regional disparities in the global burden of diphtheria across 204 countries and territories from 1990 to 2021, as well as evaluate the impact of vaccination coverage on disease transmission.: Data were extracted from the Global Burden of Disease (GBD) 2021 study. Statistical approaches, including Joinpoint regression, nonlinear fitting, and calculation of the average annual percentage change (AAPC), were employed to analyze diphtheria incidence, mortality, and disability-adjusted life years (DALYs). The Pearson correlation coefficient was used to quantify the association between diphtheria-tetanus-pertussis (DTP3) vaccination coverage and incidence. Analyses were stratified by region, sex, age, and sociodemographic index (SDI). Results: Between 1990 and 2021,the global age-standardized incidence rate (ASIR), mortality rate (ASMR), and DALY rate (ASMR) of diphtheria declined by 86.7%, 75.0%, and 86.4%, respectively, yet marked regional disparities persisted. Higher SDI levels correlated with reduced burden, with low-SDI regions accounting for 88.4% of global DALYs in 2021, while high-SDI regions approached elimination. DTP3 coverage negatively correlated with incidence (r=-0.191, p=0.011), suggesting vaccination may reduce disease burden, though weakly. We further analyzed confounders like SDI, drug resistance, health systems, surveillance gaps, and economic development. During the COVID-19 pandemic, global DTP3 coverage declined by 5 percentage points from 86% to 81%. Despite continued reductions in incidencepotentially linked to respiratory protective measures and historical immunization bufferingpost-pandemic vaccination programs must be prioritized to mitigate resurgence risks, particularly in low-SDI and endemic regions. Conclusion:Over the past three decades, global efforts have significantly reduced the diphtheria burden, but systemic challenges remain in low-SDI regions. Vaccination remains pivotal; however, post-pandemic declines in coverage underscore latent epidemic risks. Low-SDI regions require integrated nutrition-vaccination strategies, conflict-adapted delivery, and robust cold chains, while high-SDI areas should enhance genomic surveillance, adult boosters, and equitable technology sharing.This study provides the first systematic quantification of spatiotemporal diphtheria burden patterns, offering critical evidence for the WHO 2030 Diphtheria Elimination Roadmap. Eliminating regional disparities necessitates strengthened healthcare systems and adult booster immunization strategies.

Keywords: Research design, data analysis, figure creation, writing, LY: Data analysis, figure creation, writing, JB: Writing,figure creation, JR:Writing, DL: Writing, review and editing. All authors have reviewed, revised, read, and approved the final manuscript Diphtheria, Global burden of disease, sociodemographic index, Vaccination

Received: 20 Mar 2025; Accepted: 26 May 2025.

Copyright: © 2025 Wu, Lin, Zhang, Zhong and Lai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Donglan Lai, Guangdong Clinical Research, Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.